Cardenolide Glycosides (Asclepin)
PreliminaryMechanism of Action
Research Notes
Limited phytochemical characterization of A. tuberosa root cardenolides has been conducted; most published pharmacology derives from studies on related Asclepias species (A. syriaca, A. curassavica). Cytotoxic cardenolides from A. curassavica have shown IC50 values of 0.1–5 µg/mL against multiple cancer cell lines in vitro, with Na+/K+-ATPase inhibition as the primary mechanism. Anti-inflammatory activity of low-dose cardenolide fractions has been demonstrated in murine peritonitis models. No clinical trials with isolated A. tuberosa cardenolides exist; the clinical safety margin relative to cardiac toxicity at standard herbal doses has not been rigorously established in human pharmacokinetic studies.
Found In 1 Herb
3D Molecular Structure
Cardenolide Glycosides (Asclepin)
Representative pattern: C₂₁H₃₀O₂
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
